Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
STAT

STAT+: Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more

In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is fairly modest. We, , , , and . And what about you? This is a grand time to enjoy the great outdoors. Beaches and lakes are beckoning. City streets want to be strolled. And woods are inviting the adventurous for long mysterious walks. Take your pick. Or you could simply hide indoors and binge-watch something on the telly. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A CVS Deal With Illinois, A Pfizer Hemophilia Therapy, And More
CVS Caremark, one of the largest PBMs, agreed to pay at least $45 million to the state of Illinois to settle allegations that rebates were not passed through.
STAT1 min readChemistry
STAT+: The Race To Build Better CRISPR Delivery Vehicles Is Heating Up
Turning powerful gene-editing technologies into broadly useful therapies will require delivery vehicles at once more simple and far more complicated.
STAT1 min read
Opinion: Give Pharmaceutical Execs The Benefit Of Doubt — But They Need To Work For It
Pharma leaders have dual missions: advancing health and being responsible to shareholders. They must be held accountable for executing effective strategies for both.

Related Books & Audiobooks